» Articles » PMID: 34633764

Large-scale Whole-exome Sequencing Association Study Identifies FOXH1 Gene and Sphingolipid Metabolism Pathway Influencing Major Depressive Disorder

Overview
Specialties Neurology
Pharmacology
Date 2021 Oct 11
PMID 34633764
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In the present study, we performed an exome-wide investigation of the burden of rare disease-causing variants for major depressive disorder (MDD) using 16,702 samples from UK biobank. Gene-based association analysis and candidate gene prioritization analysis indicated that FOXH1 have significant association with MDD. In addition, sphingolipid metabolism pathway was found to be less enriched with rare disease-causing variants in the MDD group, suggesting that this gene set may be involved in the pathophysiology of MDD.

Citing Articles

Mutational landscape of risk variants in comorbid depression and obesity: a next-generation sequencing approach.

Perez-Gutierrez A, Carmona R, Loucera C, Cervilla J, Gutierrez B, Molina E Mol Psychiatry. 2024; 29(11):3553-3566.

PMID: 38806690 DOI: 10.1038/s41380-024-02609-2.


Integration of whole-exome sequencing and structural neuroimaging analysis in major depressive disorder: a joint study.

Oh E, Han K, Kim A, Kang Y, Tae W, Han M Transl Psychiatry. 2024; 14(1):141.

PMID: 38461185 PMC: 10924915. DOI: 10.1038/s41398-024-02849-4.


Genetic variations in the retrograde endocannabinoid signaling pathway in Chinese patients with major depressive disorder.

Xu H, Li T, Gong Q, Xu H, Hu Y, Lu W Front Neurol. 2023; 14:1153509.

PMID: 37168668 PMC: 10165312. DOI: 10.3389/fneur.2023.1153509.


Major Depressive Disorder: Existing Hypotheses about Pathophysiological Mechanisms and New Genetic Findings.

Kamran M, Bibi F, Rehman A, Morris D Genes (Basel). 2022; 13(4).

PMID: 35456452 PMC: 9025468. DOI: 10.3390/genes13040646.


Identification of putative genetic variants in major depressive disorder patients in Pakistan.

Qazi S, Irfan M, Ramzan Z, Jahanzaib M, Zaman Khan M, Nasir M Mol Biol Rep. 2022; 49(3):2283-2292.

PMID: 35040003 DOI: 10.1007/s11033-021-07050-0.

References
1.
Levey D, Stein M, Wendt F, Pathak G, Zhou H, Aslan M . Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions. Nat Neurosci. 2021; 24(7):954-963. PMC: 8404304. DOI: 10.1038/s41593-021-00860-2. View

2.
Cernackova A, Durackova Z, Trebaticka J, Mravec B . Neuroinflammation and depressive disorder: The role of the hypothalamus. J Clin Neurosci. 2020; 75:5-10. DOI: 10.1016/j.jocn.2020.03.005. View

3.
Polderman T, Benyamin B, de Leeuw C, Sullivan P, van Bochoven A, Visscher P . Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat Genet. 2015; 47(7):702-9. DOI: 10.1038/ng.3285. View

4.
Cai N, Revez J, Adams M, Andlauer T, Breen G, Byrne E . Minimal phenotyping yields genome-wide association signals of low specificity for major depression. Nat Genet. 2020; 52(4):437-447. PMC: 7906795. DOI: 10.1038/s41588-020-0594-5. View

5.
Musil R, Schwarz M, Riedel M, Dehning S, Cerovecki A, Spellmann I . Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment. J Affect Disord. 2011; 134(1-3):217-25. DOI: 10.1016/j.jad.2011.05.047. View